BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 19404564)

  • 1. Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma.
    Narita M; Hatano E; Arizono S; Miyagawa-Hayashino A; Isoda H; Kitamura K; Taura K; Yasuchika K; Nitta T; Ikai I; Uemoto S
    J Gastroenterol; 2009; 44(7):793-8. PubMed ID: 19404564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma.
    Yamashita T; Kitao A; Matsui O; Hayashi T; Nio K; Kondo M; Ohno N; Miyati T; Okada H; Yamashita T; Mizukoshi E; Honda M; Nakanuma Y; Takamura H; Ohta T; Nakamoto Y; Yamamoto M; Takayama T; Arii S; Wang X; Kaneko S
    Hepatology; 2014 Nov; 60(5):1674-85. PubMed ID: 24700365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OATP1B3 expression is strongly associated with Wnt/β-catenin signalling and represents the transporter of gadoxetic acid in hepatocellular carcinoma.
    Ueno A; Masugi Y; Yamazaki K; Komuta M; Effendi K; Tanami Y; Tsujikawa H; Tanimoto A; Okuda S; Itano O; Kitagawa Y; Kuribayashi S; Sakamoto M
    J Hepatol; 2014 Nov; 61(5):1080-7. PubMed ID: 24946283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow.
    Kogita S; Imai Y; Okada M; Kim T; Onishi H; Takamura M; Fukuda K; Igura T; Sawai Y; Morimoto O; Hori M; Nagano H; Wakasa K; Hayashi N; Murakami T
    Eur Radiol; 2010 Oct; 20(10):2405-13. PubMed ID: 20490505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI.
    Ohama H; Imai Y; Nakashima O; Kogita S; Takamura M; Hori M; Seki Y; Sawai Y; Igura T; Fukuda K; Makino Y; Morimoto O; Ohsawa M; Sakamoto M; Murakami T
    J Gastroenterol; 2014 Jun; 49(6):1081-93. PubMed ID: 23903870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy.
    Sciarra A; Schmidt S; Pellegrinelli A; Maggioni M; Dondossola D; Pasquier J; Cigala C; Tosi D; Halkic N; Bulfamante G; Viale G; Bosari S; Balabaud C; Bioulac-Sage P; Sempoux C
    Liver Int; 2019 Jan; 39(1):158-167. PubMed ID: 30218633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT.
    Inoue T; Kudo M; Komuta M; Hayaishi S; Ueda T; Takita M; Kitai S; Hatanaka K; Yada N; Hagiwara S; Chung H; Sakurai T; Ueshima K; Sakamoto M; Maenishi O; Hyodo T; Okada M; Kumano S; Murakami T
    J Gastroenterol; 2012 Sep; 47(9):1036-47. PubMed ID: 22526270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological significance of the peritumoral decreased uptake area of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid in hepatocellular carcinoma.
    Nishie A; Asayama Y; Ishigami K; Kakihara D; Nakayama T; Ushijima Y; Takayama Y; Shirabe K; Fujita N; Kubo Y; Hirakawa M; Honda H
    J Gastroenterol Hepatol; 2014 Mar; 29(3):561-7. PubMed ID: 24219648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
    Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
    J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase.
    Saito K; Kotake F; Ito N; Ozuki T; Mikami R; Abe K; Shimazaki Y
    Magn Reson Med Sci; 2005; 4(1):1-9. PubMed ID: 16127248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of Gd-EOB-DTPA by hepatocellular carcinoma: radiologic-pathologic correlation with special reference to bile production.
    Asayama Y; Tajima T; Nishie A; Ishigami K; Kakihara D; Nakayama T; Okamoto D; Fujita N; Aishima S; Shirabe K; Honda H
    Eur J Radiol; 2011 Dec; 80(3):e243-8. PubMed ID: 21109378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters.
    Leonhardt M; Keiser M; Oswald S; Kühn J; Jia J; Grube M; Kroemer HK; Siegmund W; Weitschies W
    Drug Metab Dispos; 2010 Jul; 38(7):1024-8. PubMed ID: 20406852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.
    Kim HY; Choi JY; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE; You YK; Kim DG; Jung ES
    Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between Gd-EOB-DTPA-enhanced MR imaging findings and OATP1B3 expression in chemotherapy-associated sinusoidal obstruction syndrome.
    Yoneda N; Matsui O; Ikeno H; Inoue D; Yoshida K; Kitao A; Kozaka K; Kobayashi S; Gabata T; Ikeda H; Nakamura K; Ohta T
    Abdom Imaging; 2015 Oct; 40(8):3099-103. PubMed ID: 26187715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal nodular hyperplasia-like nodule with reduced expression of organic anion transporter 1B3 in alcoholic liver cirrhosis.
    Doi N; Tomiyama Y; Kawase T; Nishina S; Yoshioka N; Hara Y; Yoshida K; Korenaga K; Korenaga M; Moriya T; Urakami A; Nakashima O; Kojiro M; Hino K
    Intern Med; 2011; 50(11):1193-9. PubMed ID: 21628934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma.
    Iwamoto T; Imai Y; Kogita S; Igura T; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Seki Y; Ohashi H; Fujita N; Kudo M; Takehara T
    Dig Dis; 2016; 34(6):679-686. PubMed ID: 27750237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy for macroscopic classification of nodular hepatocellular carcinoma: comparison of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and angiography-assisted computed tomography.
    Tada T; Kumada T; Toyoda H; Ito T; Sone Y; Okuda S; Ogawa S; Igura T; Imai Y
    J Gastroenterol; 2015 Jan; 50(1):85-94. PubMed ID: 24563123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OATP1B3 Expression in Hepatocellular Carcinoma Correlates with Intralesional Gd-EOB-DTPA Uptake and Signal Intensity on Gd-EOB-DTPA-Enhanced MRI.
    Zhou X; Long L; Mo Z; Li Y
    Cancer Manag Res; 2021; 13():1169-1177. PubMed ID: 33603462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC.
    Toyoda H; Kumada T; Tada T; Sone Y; Maeda A; Kaneoka Y
    Hepatol Int; 2015 Jan; 9(1):84-92. PubMed ID: 25788383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma?
    Kudo M
    Oncology; 2010 Jul; 78 Suppl 1():87-93. PubMed ID: 20616589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.